Zacks Research Issues Positive Outlook for Maximus Earnings

Maximus, Inc. (NYSE:MMS) – Equities researchers at Zacks Research increased their Q3 2026 EPS estimates for Maximus in a note issued to investors on Thursday, February 26th. Zacks Research analyst Team now expects that the health services provider will post earnings of $2.20 per share for the quarter, up from their prior forecast of $2.15. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Maximus’ current full-year earnings is $6.15 per share. Zacks Research also issued estimates for Maximus’ Q4 2026 earnings at $2.28 EPS, FY2026 earnings at $8.34 EPS, Q3 2027 earnings at $2.37 EPS, Q4 2027 earnings at $1.90 EPS, Q1 2028 earnings at $2.00 EPS and FY2028 earnings at $8.94 EPS.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS.

Other equities research analysts also recently issued research reports about the company. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Weiss Ratings lowered Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Maximus Stock Down 0.2%

Shares of NYSE MMS opened at $75.52 on Monday. The stock has a fifty day moving average price of $86.80 and a 200 day moving average price of $86.39. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus has a 12-month low of $63.77 and a 12-month high of $100.00. The company has a market cap of $4.12 billion, a P/E ratio of 11.49 and a beta of 0.59.

Institutional Trading of Maximus

Hedge funds and other institutional investors have recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its holdings in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after buying an additional 116 shares during the last quarter. Richardson Financial Services Inc. lifted its stake in Maximus by 123.1% during the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares during the last quarter. Advisory Services Network LLC bought a new stake in Maximus during the third quarter valued at $32,000. Canada Pension Plan Investment Board acquired a new stake in shares of Maximus during the second quarter worth $35,000. Finally, Cullen Frost Bankers Inc. bought a new position in shares of Maximus in the 3rd quarter worth about $38,000. 97.21% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, insider Michelle F. Link sold 4,039 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the sale, the insider owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David Mutryn purchased 1,000 shares of Maximus stock in a transaction dated Monday, February 9th. The shares were bought at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the transaction, the chief financial officer directly owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 1.80% of the company’s stock.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, February 13th. This is an increase from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.7%. Maximus’s dividend payout ratio is 20.09%.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.